Macquarie Group’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1870 |
|
|
2022
Q3 | – | Sell |
-942
| Closed | -$25K | – | 2114 |
|
|
2022
Q2 | $25K | Hold |
942
| – | – | ﹤0.01% | 2239 |
|
|
2022
Q1 | $32 | Hold |
942
| – | – | ﹤0.01% | 2272 |
|
|
2021
Q4 | $36K | Hold |
942
| – | – | ﹤0.01% | 2256 |
|
|
2021
Q3 | $51K | Buy |
+942
| New | +$51K | ﹤0.01% | 2225 |
|
|
2021
Q1 | – | Sell |
-4,874
| Closed | -$85K | – | 2467 |
|
|
2020
Q4 | $85K | Buy |
+4,874
| New | +$85K | ﹤0.01% | 1906 |
|
|
2019
Q1 | – | Sell |
-52,000
| Closed | -$10K | – | 1704 |
|
|
2018
Q4 | $10K | Hold |
52,000
| – | – | ﹤0.01% | 1923 |
|
|
2018
Q3 | $23K | Buy |
52,000
+15,900
| +44% | +$7.03K | ﹤0.01% | 1875 |
|
|
2018
Q2 | $18K | Buy |
+36,100
| New | +$18K | ﹤0.01% | 2071 |
|
|
2018
Q1 | – | Sell |
-2,900
| Closed | -$8K | – | 2198 |
|
|
2017
Q4 | $8K | Buy |
+2,900
| New | +$8K | ﹤0.01% | 2302 |
|
|
2016
Q1 | – | Sell |
-120,721
| Closed | -$1.89M | – | 1537 |
|
|
2015
Q4 | $1.89M | Buy |
120,721
+36,693
| +44% | +$575K | ﹤0.01% | 948 |
|
|
2015
Q3 | $886K | Buy |
84,028
+28,328
| +51% | +$299K | ﹤0.01% | 1152 |
|
|
2015
Q2 | $1.41M | Buy |
55,700
+11,000
| +25% | +$277K | ﹤0.01% | 1109 |
|
|
2015
Q1 | $1.25M | Sell |
44,700
-9,000
| -17% | -$251K | ﹤0.01% | 1105 |
|
|
2014
Q4 | $980K | Hold |
53,700
| – | – | ﹤0.01% | 1169 |
|
|
2014
Q3 | $696K | Hold |
53,700
| – | – | ﹤0.01% | 1201 |
|
|
2014
Q2 | $876K | Buy |
53,700
+25,000
| +87% | +$408K | ﹤0.01% | 1218 |
|
|
2014
Q1 | $507K | Buy |
28,700
+12,000
| +72% | +$212K | ﹤0.01% | 1278 |
|
|
2013
Q4 | $404K | Buy |
+16,700
| New | +$404K | ﹤0.01% | 1271 |
|